To further explore the relationship between NFE2L3 expression and prognosis, overall survival (OS), progression-free survival (PFS), and disease-free survival (DSS) analyses with median group cutoff by univariate Cox regression analysis for pan-cancers were performed. Here, NFE2L3 is linked to cancer.